Human CMV immediate-early enhancer: A useful tool to enhance cell-type-specific expression from lentiviral vectors

Journal of Gene Medicine

Volumn 10, Issue 1, 2008, Pages 21-32

  Gruh, Ina ^a   Wunderlich, Stephanie ^a   Winkler, Monica ^a   Schwanke, Kristin ^a   Heinke, Jennifer ^a   Blömer, Ulrike ^a   Ruhparwar, Arjang ^a   Rohde, Bettina ^a   Li, Ren Ke ^b   Haverich, Axel ^a   Martin, Ulrich ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

CMV enhancer; Gene transfer; Lentiviral vector; Tissue specific expression

Indexed keywords

ATRIAL NATRIURETIC FACTOR; GREEN FLUORESCENT PROTEIN; HEART VENTRICLE MYOSIN LIGHT CHAIN; LENTIVIRUS VECTOR; MYOSIN LIGHT CHAIN; PHOSPHOGLYCERATE KINASE; SURFACTANT PROTEIN C; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL SPECIFICITY; CELL TYPE; CONTROLLED STUDY; CYTOMEGALOVIRUS; DRUG SCREENING; GENE CASSETTE; GENE EXPRESSION; GENE INSERTION; GENE TRANSFER; GENETIC TRANSDUCTION; HEART MUSCLE CELL; HUMAN; HUMAN CELL; LUNG ALVEOLUS EPITHELIUM; MOUSE; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; REPORTER GENE; TARGET CELL; TRANSCRIPTION REGULATION; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; ATRIAL NATRIURETIC FACTOR; CELLS, CULTURED; CYTOMEGALOVIRUS; ENHANCER ELEMENTS (GENETICS); GENE EXPRESSION REGULATION; GENETIC VECTORS; HELA CELLS; HUMANS; LENTIVIRUS; MYOCYTES, CARDIAC; ORGAN SPECIFICITY; PROMOTER REGIONS (GENETICS); PULMONARY SURFACTANT-ASSOCIATED PROTEIN C; RATS; RATS, WISTAR; RNA, MESSENGER; TRANSGENES; VIRION; VIRUS ASSEMBLY;

HUMAN HERPESVIRUS 5; WOODCHUCK HEPATITIS VIRUS;

EID: 38349104204     PISSN: 1099498X     EISSN: 15212254     Source Type: Journal    
DOI: 10.1002/jgm.1122     Document Type: Article

References (32)

1. Naldini L, et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 1996; 272: 263-267.
2. Kafri T, et al. Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors. Nat Genet 1997; 17: 314-317.
3. Pfeifer A, Ikawa M, Dayn Y, Verma IM. Transgenesis by lentiviral vectors: lack of gene silencing in mammalian embryonic stem cells and preimplantation embryos. Proc Natl Acad Sci U S A 2002; 99: 2140-2145.
4. Vigna E, Naldini L. Lentiviral vectors: excellent tools for experimental gene transfer and promising candidates for gene therapy. J Gene Med 2000; 2: 308-316.
5. Kumar M, Keller B, Makalou N, Sutton RE. Systematic determination of the packaging limit of lentiviral vectors. Hum Gene Ther 2001; 12: 1893-1905.
6. Miller N, Vile R. Targeted vectors for gene therapy. FASEB J 1995; 9: 190-199.
7. De Palma M, Venneri MA, Naldini L. In vivo targeting of tumor endothelial cells by systemic delivery of lentiviral vectors. Hum Gene Ther 2003; 14: 1193-1206.
8. Iyer M, et al. Bioluminescence imaging of systemic tumor targeting using a prostate-specific lentiviral vector. Hum Gene Ther 2006; 17: 125-132.
9. Nettelbeck DM, Jerome V, Muller R. A strategy for enhancing the transcriptional activity of weak cell type-specific promoters. Gene Ther 1998; 5: 1656-1664.
10. Zufferey R, Donello JE, Trono D, Hope TJ. Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors. J Virol 1999; 73: 2886-2892.
11. Boshart M, et al. A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus. Cell 1985; 41: 521-530.
12. Zufferey R, et al. Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J Virol 1998; 72: 9873-9880.
13. Gruh I, et al. Shuttle system allowing simplified cloning of expression cassettes into advanced generation lentiviral vectors. Biotechniques 2005; 38: 530-534.
14. Demaison C, et al. High-level transduction and gene expression in hematopoietic repopulating cells using a human immunodeficiency [correction of imunodeficiency] virus type 1-based lentiviral vector containing an internal spleen focus forming virus promoter. Hum Gene Ther 2002; 13: 803-813.
15. Glasser SW, et al. Altered stability of pulmonary surfactant in SP-C-deficient mice. Proc Natl Acad Sci U S A 2001; 98: 6366-6371.
16. Gruh I, et al. No evidence of transdifferentiation of human endothelial progenitor cells into cardiomyocytes after coculture with neonatal rat cardiomyocytes. Circulation 2006; 113: 1326-1334.
17. Claycomb WC, et al. HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte. Proc Natl Acad Sci U S A 1998; 95: 2979-2984.
18. Simms E, Gazdar AF, Abrams PG, Minna JD. Growth of human small cell (oat cell) carcinoma of the lung in serum-free growth factor-supplemented medium. Cancer Res 1980; 40: 4356-4363.
19. Martin U, et al,. Expression of pig endogenous retrovirus by primary porcine endothelial cells and infection of human cells. Lancet 1998; 352: 692-694.
20. Dull T, et al. A third-generation lentivirus vector with a conditional packaging system. J Virol 1998; 72: 8463-8471.
21. Gotoh A, et al. Development of prostate-specific antigen promoter-based gene therapy for androgen-independent human prostate cancer. J Urol 1998; 160: 220-229.
22. Li HW, Li J, Helm GA, Pan D. Highly specific expression of luciferase gene in lungs of naive nude mice directed by prostate-specific antigen promoter. Biochem Biophys Res Commun 2005; 334: 1287-1291.
23. Wu L, et al. Chimeric PSA enhancers exhibit augmented activity in prostate cancer gene therapy vectors. Gene Ther 2001; 8: 1416-1426.
24. Shubeita HE, et al. Transcriptional activation of the cardiac myosin light chain 2 and atrial natriuretic factor genes by protein kinase C in neonatal rat ventricular myocytes. Proc Natl Acad Sci U S A 1992; 89: 1305-1309.
25. Boecker W, et al. Cardiac-specific gene expression facilitated by an enhanced myosin light chain promoter. Mol Imaging 2004; 3: 69-75.
26. Su H, et al. Adeno-associated viral vector delivers cardiac-specific and hypoxia-inducible VEGF expression in ischemic mouse hearts. Proc Natl Acad Sci U S A 2004; 101: 16280-16285.
27. Knowlton KU, et al. Co-regulation of the atrial natriuretic factor and cardiac myosin light chain-2 genes during alpha-adrenergic stimulation of neonatal rat ventricular cells. Identification of cis sequences within an embryonic and a constitutive contractile protein gene which mediate inducible expression. J Biol Chem 1991; 266: 7759-7768.
28. Cantin M, et al. Atrial natriuretic factor in the impulse-conduction system of rat cardiac ventricles. Cell Tissue Res 1989; 256: 309-325.
29. Harrod KS, et al. Lung-specific expression of adenovirus E3-14.7K in transgenic mice attenuates adenoviral vector-mediated lung inflammation and enhances transgene expression. Hum Gene Ther 1998; 9: 1885-1898.
30. Sawicki JA, et al,. A composite CMV-IE enhancer/beta-actin promoter is ubiquitously expressed in mouse cutaneous epithelium. Exp Cell Res 1998; 244: 367-369.
31. Liu BH, Wang X, Ma YX, Wang S. CMV enhancer/human PDGF-beta promoter for neuron-specific transgene expression. Gene Ther 2004; 11: 52-60.
32. Wikenheiser KA, et al. Production of immortalized distal respiratory epithelial cell lines from surfactant protein C/simian virus 40 large tumor antigen transgenic mice. Proc Natl Acad Sci U S A 1993; 90: 11029-11033.